CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 56 enrolled
Drug / intervention
fentanyl +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03105115
NCT03105115N/ACompleted

Effect of Intrathecal Fentanyl on Spinal Anesthesia During Dexmedetomidine

Seoul National University Hospital·interventional·Posted Apr 7, 2017·Updated Aug 29, 2018

In Brief

A clinical study evaluating fentanyl and bupivacaine only for Anesthesia, Spinal. Completed, enrolled 56 participants across 1 site.

Detailed Summary

Intravenous infusion of dexmedetomidine during procedure was known to be associated prolonged duration of spinal anesthesia. In patients receiving dexmedetomidine infusion during procedure, it has been not evaluated whether use of adjuvant intrathecal fentanyl had additional prolonging effect on duration of spinal anesthesia or not. Therefore, the investigators planned this trial to compare clinical outcomes in patients receiving spinal anesthesia with heavy bupivacaine only and heavy bupivacaine plus fentanyl adjuvant.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesSouth Korea
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedApr 7, 2017
Enrollment StartMay 25, 2017
Primary CompletionOct 24, 2017
Study CompletionOct 26, 2017
TodayJul 1, 2026
Enrollment to primary: 5 monthsPosted 9.2 years ago

Interventions

fentanyldrug

intrathecal fentanyl will be added as adjuvant for spinal anesthesia using heavy bupivacaine, while dexmedetomidine will be infused intravenously during operation

bupivacaine onlydrug

heavy bupivacaine will be injected intrathecally during spinal anesthesia, without fentanyl, while dexmedetomidine will be infused intravenously during operation